Ramona Doyle

Chief Executive Officer chez The MAVEN Project

65 ans

Consumer Services

Health Technology

Government

Profil

Actuellement, Ramona Doyle est médecin en chef de Recursion Pharmaceuticals, Inc.

Sociétés	Poste	Début
The MAVEN Project	Chief Executive Officer	01/09/2020
The University of California, San Francisco	Corporate Officer/Principal	01/10/2011

Sociétés	Poste	Fin
RECURSION PHARMACEUTICALS, INC.	Chief Tech/Sci/R&D Officer	07/06/2022
Blade Therapeutics, Inc. Blade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Blade Therapeutics, Inc. offers anti-fibrotic therapies to meet unserved patient needs. Its product portfolio is to address various fibrotic diseases and their underlying pathophysiology. The company was founded by Hal Dietz and Wendye R. Robbins and is headquartered in South San Francisco, CA.	Chief Tech/Sci/R&D Officer	01/05/2018
California Institute for Regenerative Medicine	Corporate Officer/Principal	01/07/2016
Stanford University School of Medicine	Corporate Officer/Principal	01/01/2008

University of Oxford	Graduate Degree
Sewanee-The University of the South	Undergraduate Degree
Emory University School of Medicine	Doctorate Degree

Actives

Inactives

Sociétés cotées

Entreprise privées

100 +

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés cotées	1
RECURSION PHARMACEUTICALS, INC.	Health Technology

Entreprise privées	3
California Institute for Regenerative Medicine	Government
Blade Therapeutics, Inc. Blade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Blade Therapeutics, Inc. offers anti-fibrotic therapies to meet unserved patient needs. Its product portfolio is to address various fibrotic diseases and their underlying pathophysiology. The company was founded by Hal Dietz and Wendye R. Robbins and is headquartered in South San Francisco, CA.	Commercial Services
The MAVEN Project